Wellington Management Group
JAZZ icon

Wellington Management Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Wellington Management Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-520
Closed -$809K – 2256
2017
Q4 		$809K Sell
520
-46
-8% -$6.38K ﹤0.01% 1946
2017
Q3 		$580K Buy
566
+366
+183% +$55.4K ﹤0.01% 2010
2017
Q2 		$221K Buy
+200
New +$30.6K ﹤0.01% 2157

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Wellington Management Group's JAZZ Position: Q1 2026 in Review

Wellington Management Group increased its Jazz Pharmaceuticals (JAZZ) stake by 307% in Q1 2026, buying an estimated $60.4M and bringing the position to 458,014 shares worth $86.6M. The position accounts for 0.02% of the portfolio, ranked #583.

Wellington Management Group first reported a position in JAZZ in Q2 2013 and has held it in 48 quarters since. The position peaked at $409M in Q1 2022. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Wellington Management Group held 458,014 shares of Jazz Pharmaceuticals worth $86.6M as of Q1 2026.
  • Wellington Management Group bought 345,454 Jazz Pharmaceuticals shares in Q1 2026, an estimated $60.4M.
  • Jazz Pharmaceuticals made up 0.02% of Wellington Management Group's portfolio in Q1 2026, its #583 holding.
  • Wellington Management Group first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 48 quarters since.
  • Wellington Management Group's Jazz Pharmaceuticals position peaked at $409M in Q1 2022.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.